Applied DNA Sciences, Inc. NASDAQ:APDN

Applied DNA Sciences stock price today

$3.58
+3.4
+1888.89%
Financial Health
0
1
2
3
4
5
6
7
8
9

Applied DNA Sciences stock price monthly change

-58.42%
month

Applied DNA Sciences stock price quarterly change

-58.42%
quarter

Applied DNA Sciences stock price yearly change

-70.94%
year

Applied DNA Sciences key metrics

Market Cap
9.30M
Enterprise value
N/A
P/E
-1.86
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
0.71
Price/Book
1.49
PEG ratio
-0.03
EPS
-14.30
Revenue
9.03M
EBITDA
-15.63M
Income
-10.57M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-38.93%
Oper. margin
-54.79%
Gross margin
32.82%
EBIT margin
-54.79%
EBITDA margin
-173.05%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Applied DNA Sciences stock price history

Applied DNA Sciences stock forecast

Applied DNA Sciences financial statements

Applied DNA Sciences, Inc. (NASDAQ:APDN): Profit margin
Mar 2023 4.40M 588.34K 13.35%
Jun 2023 2.91M -3.09M -106.25%
Sep 2023 779.73K -3.59M -460.7%
Mar 2024 929.63K -4.47M -480.89%
Applied DNA Sciences, Inc. (NASDAQ:APDN): Analyst Estimates
Sep 2023 779.73K -3.59M -460.7%
Mar 2024 929.63K -4.47M -480.89%
Sep 2025 2.2M -24.61M -1118.74%
Oct 2025 1.8M -148.12K -8.23%
  • Analysts Price target

  • Financials & Ratios estimates

Applied DNA Sciences, Inc. (NASDAQ:APDN): Earnings per share (EPS)
2024-08-08 -0.35 0.47
0%
Yield TTM
Applied DNA Sciences, Inc. (NASDAQ:APDN): Payout ratio
Payout ratio 0%
Applied DNA Sciences, Inc. (NASDAQ:APDN): Dividend Yield
2020
2021
2022 1.09%
2023
2024 9.05%
Applied DNA Sciences, Inc. (NASDAQ:APDN): Debt to assets
Mar 2023 19175477 9.20M 48.02%
Jun 2023 15789534 8.59M 54.44%
Sep 2023 13651577 8.77M 64.31%
Mar 2024 9175627 9.35M 101.91%
Applied DNA Sciences, Inc. (NASDAQ:APDN): Cash Flow
Mar 2023 214.38K -54.33K 0
Jun 2023 -1.36M -161.8K 0
Sep 2023 -2.67M -924.66K 0
Mar 2024 -3.20M -14.82K 3.01M

Applied DNA Sciences alternative data

Applied DNA Sciences, Inc. (NASDAQ:APDN): Employee count
Aug 2023 61
Sep 2023 61
Oct 2023 61
Nov 2023 61
Dec 2023 61
Jan 2024 52
Feb 2024 52
Mar 2024 52
Apr 2024 52
May 2024 52
Jun 2024 52
Jul 2024 52

Applied DNA Sciences other data

8.85% -13.50%
of APDN is owned by hedge funds
1.14M -862.04K
shares is hold by hedge funds

Applied DNA Sciences, Inc. (NASDAQ:APDN): Insider trades (number of shares)
Period Buy Sel
Jun 2020 745000 0
Mar 2021 0 13049
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ANCHIN SCOTT L director Common Stock 13,049 $8.48 $110,603
Option
ANCHIN SCOTT L director Stock Option (right to buy) 20,834 $4.26 $88,753
Option
ANCHIN SCOTT L director Common Stock 13,049 $2.22 $28,904
Purchase
MONTGOMERY WILLIAM W other: ex 5% owner
Applied DNA Sciences Inc. Common Stock 190,000 N/A N/A
Purchase
MONTGOMERY WILLIAM W other: ex 5% owner
Applied DNA Sciences Inc. 5 year warrant 110,000 $5.25 $577,500
Purchase
MONTGOMERY WILLIAM W other: ex 5% owner
Applied DNA Sciences Inc. Common Stock 80,000 N/A N/A
Purchase
MONTGOMERY WILLIAM W other: ex 5% owner
Applied DNA Sciences Inc. Common Stock 40,000 N/A N/A
Purchase
MONTGOMERY WILLIAM W other: ex 5% owner
Applied DNA Sciences Inc. 5 year warrant 40,000 $5.25 $210,000
Purchase
MONTGOMERY WILLIAM W other: ex 5% owner
Applied DNA Sciences Inc. Common Stock 115,000 N/A N/A
Purchase
MONTGOMERY WILLIAM W other: ex 5% owner
Applied DNA Sciences Inc. 5 year warrant 75,000 $5.25 $393,750
Patent
Application
Filling date: 19 Mar 2021 Issue date: 23 Sep 2021
Application
Filling date: 17 Dec 2019 Issue date: 25 Jun 2020
Wednesday, 18 December 2024
accesswire.com
Tuesday, 17 December 2024
zacks.com
accesswire.com
Monday, 16 December 2024
accesswire.com
Wednesday, 30 October 2024
accesswire.com
Tuesday, 15 October 2024
accesswire.com
Wednesday, 18 September 2024
accesswire.com
Tuesday, 17 September 2024
accesswire.com
accesswire.com
Wednesday, 11 September 2024
accesswire.com
Wednesday, 4 September 2024
accesswire.com
Friday, 23 August 2024
benzinga.com
accesswire.com
Monday, 19 August 2024
accesswire.com
zacks.com
Sunday, 11 August 2024
seekingalpha.com
Thursday, 8 August 2024
zacks.com
accesswire.com
Wednesday, 7 August 2024
accesswire.com
Monday, 29 July 2024
accesswire.com
accesswire.com
Thursday, 25 July 2024
accesswire.com
Thursday, 18 July 2024
accesswire.com
Thursday, 27 June 2024
zacks.com
zacks.com
Thursday, 20 June 2024
accesswire.com
Tuesday, 18 June 2024
accesswire.com
Thursday, 13 June 2024
accesswire.com
Monday, 10 June 2024
benzinga.com
zacks.com
  • What's the price of Applied DNA Sciences stock today?

    One share of Applied DNA Sciences stock can currently be purchased for approximately $3.58.

  • When is Applied DNA Sciences's next earnings date?

    Applied DNA Sciences, Inc. is estimated to report earnings on Wednesday, 6 Aug 2025.

  • Does Applied DNA Sciences pay dividends?

    No, Applied DNA Sciences does not pay dividends.

  • How much money does Applied DNA Sciences make?

    Applied DNA Sciences has a market capitalization of 9.30M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 74.33% to 3.43M US dollars. Applied DNA Sciences made a loss 7.23M US dollars in net income (profit) last year or $0.47 on an earnings per share basis.

  • What is Applied DNA Sciences's stock symbol?

    Applied DNA Sciences, Inc. is traded on the NASDAQ under the ticker symbol "APDN".

  • What is Applied DNA Sciences's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Applied DNA Sciences?

    Shares of Applied DNA Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Applied DNA Sciences's key executives?

    Applied DNA Sciences's management team includes the following people:

    • Dr. James A. Hayward Ph.D., Sc.D. Chairman, Pres & Chief Executive Officer(age: 71, pay: $391,620)
    • Mr. Scott L. Anchin Strategic Advisor & Independent Director(age: 51, pay: $325,000)
    • Ms. Judith Murrah Chief Operating Officer & Sec.(age: 67, pay: $278,270)
    • Ms. Beth M. Jantzen CPA, CPA Chief Financial Officer(age: 49, pay: $278,270)
  • How many employees does Applied DNA Sciences have?

    As Jul 2024, Applied DNA Sciences employs 52 workers.

  • When Applied DNA Sciences went public?

    Applied DNA Sciences, Inc. is publicly traded company for more then 22 years since IPO on 15 Jul 2003.

  • What is Applied DNA Sciences's official website?

    The official website for Applied DNA Sciences is adnas.com.

  • Where are Applied DNA Sciences's headquarters?

    Applied DNA Sciences is headquartered at 50 Health Sciences Drive, Stony Brook, NY.

  • How can i contact Applied DNA Sciences?

    Applied DNA Sciences's mailing address is 50 Health Sciences Drive, Stony Brook, NY and company can be reached via phone at +63 18408800.

Applied DNA Sciences company profile:

Applied DNA Sciences, Inc.

adnas.com
Exchange:

NASDAQ

Full time employees:

52

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims. It also manufactures and sells COVID-19 PCR-based molecular diagnostic test kit under the LineaTM COVID-19 Assay Kit trademark; and COVID-19 diagnostic test kit to prevent virus spread within a community, school, or workplace under the safeCircle trademark. In addition, the company provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets; and contract research services to RNA based drug and biologic customers for preclinical studies. Further, it develops an invasive circulating tumor cell capture and identification technology that uses a patented functional assay to capture live invasive circulating tumor cell and associated lymphocytes. The company operates in the United States, Europe, Asia, and internationally. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.

50 Health Sciences Drive
Stony Brook, NY 11790

CIK: 0000744452
ISIN: US03815U3005
CUSIP: 03815U300